Liposome‐Enabled Nanomaterials for Muscle Regeneration
Small Methods · 2025
DOI: 10.1002/smtd.202402154 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Small Methods, 2025. Verfasst von Shuang Wu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Skaggs Pharmaceutical Sciences Center, Department of Pharmacology & Toxicology, R. Ken Coit College of Pharmacy, The University of Arizona, Tucson, A…. Hauptthemen laut MEDLINE: Liposomes, Regeneration, Nanostructures, Muscle, Skeletal. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 215 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, NCI NIH HHS, UArizona Comprehensive Cancer Center Internal Pilot Award.
Abstract (Originalsprache)
Muscle regeneration is a vital biological process that is crucial for maintaining muscle function and integrity, particularly for the treatment of muscle diseases such as sarcopenia and muscular dystrophy. Generally, muscular tissues can self‐repair and regenerate under various conditions, including acute or chronic injuries, aging, and genetic mutation. However, regeneration becomes challenging beyond a certain threshold, particularly in severe muscle injuries or progressive diseases. In recent years, liposome‐based nanotechnologies have shown potential as promising therapeutic strategies for muscle regeneration. Liposomes offer an adaptable platform for targeted drug delivery due to their cell membrane‐like structure and excellent biocompatibility. They can enhance drug solubility, stability, and targeted delivery while minimizing systemic side effects by different mechanisms. This review summarizes recent advancements, discusses current applications and mechanisms, and highlights challenges and future directions for possible clinical translation of liposome‐based nanomaterials in the treatment of muscle diseases. It is hoped this review offers new insights into the development of liposome‐enabled nanomedicine to address current limitations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Skaggs Pharmaceutical Sciences Center, Department of Pharmacology & Toxicology, R. Ken Coit College of Pharmacy, The University of Arizona, Tucson, AZ, 85721, USA.
- Clinical and Translational Oncology Program, The University of Arizona Cancer Center, Tucson, AZ, 85721, USA.
- BIO5 Institute, The University of Arizona, Tucson, AZ, 85721, USA.
- Southwest Environmental Health Sciences Center, The University of Arizona, Tucson, AZ, 85721, USA.
ORCID-Profile: Jianqin Lu
Förderung
- NIH HHS
- NCI NIH HHS
- UArizona Comprehensive Cancer Center Internal Pilot Award
- Startup and Retention Funds from the R. Ken Coit College of Pharmacy at The University of Arizona (UArizona)
- PhRMA Foundation Faculty Starter Grant in Drug Delivery
- NIGMS NIH HHS
- National Institutes of Health
Zitieren
APA
Wu, S., & Lu, J. (2025). Liposome‐Enabled Nanomaterials for Muscle Regeneration. Small Methods. https://doi.org/10.1002/smtd.202402154
Vancouver
Wu S, Lu J. Liposome‐Enabled Nanomaterials for Muscle Regeneration. Small Methods. 2025. doi:10.1002/smtd.202402154
BibTeX
@article{Wu2025,
author = {Wu, Shuang and Lu, Jianqin},
title = {Liposome‐Enabled Nanomaterials for Muscle Regeneration},
journal = {Small Methods},
year = {2025},
doi = {10.1002/smtd.202402154}
}
EUVIMED